Aromatase inhibitors: a dose-response effect?

Endocr Relat Cancer. 1999 Jun;6(2):245-9. doi: 10.1677/erc.0.0060245.
No abstract available

Publication types

  • Review

MeSH terms

  • Aminoglutethimide / pharmacology
  • Aminoglutethimide / therapeutic use
  • Anastrozole
  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Aromatase Inhibitors*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology*
  • Enzyme Inhibitors / therapeutic use
  • Estrogens / metabolism*
  • Fadrozole / pharmacology
  • Fadrozole / therapeutic use
  • Humans
  • Letrozole
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Neoplasms, Hormone-Dependent / metabolism
  • Nitriles / pharmacology
  • Nitriles / therapeutic use
  • Triazoles / pharmacology
  • Triazoles / therapeutic use

Substances

  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Enzyme Inhibitors
  • Estrogens
  • Nitriles
  • Triazoles
  • Aminoglutethimide
  • Anastrozole
  • Letrozole
  • Fadrozole